The Jefferies Group LLC Begins Coverage on Arix Bioscience PLC (ARIX)

The Jefferies Group LLC Begins Coverage on Arix Bioscience PLC (ARIX)

Shares of Arix Bioscience PLC (ARIX) opened at 215.00 on Monday. Arix Bioscience PLC has a 12 month low of GBX 169.50 and a 12 month high of GBX 218.00. The company’s market cap is GBX 279.25 million. The firm’s 50 day moving average is GBX 200.06 and its 200 day moving average is GBX 200.74.

Jefferies Group LLC initiated coverage on shares of Arix Bioscience PLC (LON:ARIX) in a research note issued to investors on Monday, May 15th. The firm issued a buy rating and a GBX 245 ($3.15) price target on the stock.

In other news, insider James Rawlingson purchased 11,484 shares of the company’s stock in a transaction on Monday, May 8th. The stock was acquired at an average price of GBX 202 ($2.59) per share, with a total value of £23,197.68 ($29,797.92). Arix Bioscience PLC Company Profile

Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. Its principal activity is to source, finance and develop healthcare and life science businesses across the world.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “LSE:ARIX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment